Literature DB >> 7760990

Behavior-dependent and drug-induced changes of rat visual evoked potential: relation to the EEG spectral power.

A Bringmann1, F Klingberg.   

Abstract

The relation between EEG spectral power and alterations of the visual evoked potential (VEP) during different behavioral states and after intraperitoneal application of neuroactive drugs have been investigated in Long-Evans rats. FFT power and field potential maps were made in five behavioral states of the unrestrained rat: exploratory sniffing, face washing, relaxed waking immobility, slow wave sleep, and during cortical high-voltage spindling. Fourteen epidural electrodes were implanted in the bulbus olfactorius, in the frontal areas Fr2 and Fr1, in the visual areas 18 and 17, and in the cerebellum of the right hemisphere. Two regions in the investigated cortex were found to be the probable origins of slow delta and theta waves: the frontal cortex and the anterior area 18. Area 17 does not express prominent EEG frequencies that contribute to the cortical EEG in any of the investigated behavioral states. The VEP was found to originate in area 17. The neural activity of the occipital cortex is reflected in the VEP whereas the occipital EEG possibly reflects the hippocampal activity in some behavioral states. This may be a reason for partly independent changes of VEP and EEG during different behavioral states and after application of neuroactive drugs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7760990     DOI: 10.1159/000119178

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  2 in total

1.  Trial-to-trial variability and state-dependent modulation of auditory-evoked responses in cortex.

Authors:  M A Kisley; G L Gerstein
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

2.  Influence of narcotics on luminance and frequency modulated visual evoked potentials in rats.

Authors:  T Jehle; D Ehlken; K Wingert; T J Feuerstein; M Bach; W A Lagrèze
Journal:  Doc Ophthalmol       Date:  2009-01-04       Impact factor: 2.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.